Novel Diagnostic Approaches to Adamantiades-Behcet's Disease

A 10 year old boy had visual deterioration in both eyes. Visual acuity was 0.2 in the right and 0.3 in the left eye. Further ophthalmologic findings were typical of posterior uveitis. The pediatric physical examination also disclosed aphthous stomatitis and recurrent aphthous genital ulcers. At diag...

Full description

Bibliographic Details
Main Authors: M. Hatzistilianou, S. Hitoglou, D. Gougoustamou, M. Antoniades, S. Pappa, A. Doudou
Format: Article
Language:English
Published: SAGE Publishing 2005-05-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X0500300208
id doaj-c924708cac2d43b3884f145b90c39a52
record_format Article
spelling doaj-c924708cac2d43b3884f145b90c39a522020-11-25T03:24:03ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2005-05-01310.1177/1721727X0500300208Novel Diagnostic Approaches to Adamantiades-Behcet's DiseaseM. HatzistilianouS. Hitoglou0D. Gougoustamou1M. Antoniades2S. PappaA. Doudou3 General Biology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece General Biology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece General Biology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece Ophalmology Department, Aristotle University of Thessaloniki, Thessaloniki GreeceA 10 year old boy had visual deterioration in both eyes. Visual acuity was 0.2 in the right and 0.3 in the left eye. Further ophthalmologic findings were typical of posterior uveitis. The pediatric physical examination also disclosed aphthous stomatitis and recurrent aphthous genital ulcers. At diagnosis serum levels of IL-1β, IL-6, IL-8, TNF-α, sIL-2R, MCP-1, VEGF, tADA activity in the patient with active and ABD relapse were significantly higher than those in the inactive period of the disease, suggesting that these parameters may be related to disease activity. In addition to the proinflammatory chemokines and cytokines, plasma levels of VEGF and serum tADA activity may be used for the diagnosis of ABD and for monitoring the effect of treatment, as well as the follow-up period. Also, further studies of VEGF may lead to novel therapies with antibodies or other VEGF inhibitors.https://doi.org/10.1177/1721727X0500300208
collection DOAJ
language English
format Article
sources DOAJ
author M. Hatzistilianou
S. Hitoglou
D. Gougoustamou
M. Antoniades
S. Pappa
A. Doudou
spellingShingle M. Hatzistilianou
S. Hitoglou
D. Gougoustamou
M. Antoniades
S. Pappa
A. Doudou
Novel Diagnostic Approaches to Adamantiades-Behcet's Disease
European Journal of Inflammation
author_facet M. Hatzistilianou
S. Hitoglou
D. Gougoustamou
M. Antoniades
S. Pappa
A. Doudou
author_sort M. Hatzistilianou
title Novel Diagnostic Approaches to Adamantiades-Behcet's Disease
title_short Novel Diagnostic Approaches to Adamantiades-Behcet's Disease
title_full Novel Diagnostic Approaches to Adamantiades-Behcet's Disease
title_fullStr Novel Diagnostic Approaches to Adamantiades-Behcet's Disease
title_full_unstemmed Novel Diagnostic Approaches to Adamantiades-Behcet's Disease
title_sort novel diagnostic approaches to adamantiades-behcet's disease
publisher SAGE Publishing
series European Journal of Inflammation
issn 1721-727X
publishDate 2005-05-01
description A 10 year old boy had visual deterioration in both eyes. Visual acuity was 0.2 in the right and 0.3 in the left eye. Further ophthalmologic findings were typical of posterior uveitis. The pediatric physical examination also disclosed aphthous stomatitis and recurrent aphthous genital ulcers. At diagnosis serum levels of IL-1β, IL-6, IL-8, TNF-α, sIL-2R, MCP-1, VEGF, tADA activity in the patient with active and ABD relapse were significantly higher than those in the inactive period of the disease, suggesting that these parameters may be related to disease activity. In addition to the proinflammatory chemokines and cytokines, plasma levels of VEGF and serum tADA activity may be used for the diagnosis of ABD and for monitoring the effect of treatment, as well as the follow-up period. Also, further studies of VEGF may lead to novel therapies with antibodies or other VEGF inhibitors.
url https://doi.org/10.1177/1721727X0500300208
work_keys_str_mv AT mhatzistilianou noveldiagnosticapproachestoadamantiadesbehcetsdisease
AT shitoglou noveldiagnosticapproachestoadamantiadesbehcetsdisease
AT dgougoustamou noveldiagnosticapproachestoadamantiadesbehcetsdisease
AT mantoniades noveldiagnosticapproachestoadamantiadesbehcetsdisease
AT spappa noveldiagnosticapproachestoadamantiadesbehcetsdisease
AT adoudou noveldiagnosticapproachestoadamantiadesbehcetsdisease
_version_ 1724603756775997440